Why Am I Not Losing Weight on Ozempic? 11 Reasons—Backed by Science

Ozempic has become one of the most talked-about medications in recent years, not just for diabetes but for its dramatic weight loss potential. Yet many people find themselves asking: Why am I not losing weight on Ozempic?

It can feel especially discouraging when the medication seems to work spectacularly for everyone else. Social media is filled with before-and-after photos, while clinical trials report double-digit average weight loss. When your own body does not follow the same trajectory, it is easy to assume that you are doing something wrong—but it’s likely that you are not!

You may still be early in the dosage-escalation process. You may be comparing your results with studies that used a different semaglutide product and a higher dose. Your treatment may have been interrupted, or your appetite may not have changed very much. You may also be a genuine low responder—or you may have already responded and reached a normal plateau.

As a board-certified health and wellness coach with over a decade of experience as a medical writer, I know how to parse through the clinical evidence so that you don’t have to. Let’s look at what semaglutide actually does, why weight loss results vary so much, and what you can do next without intensifying fear, shame, or compulsive eating.

How Does Ozempic Work for Weight Loss?

Ozempic contains semaglutide, a medication that activates receptors for a hormone called glucagon-like peptide-1, or GLP-1.

GLP-1 receptor agonists (that’s the formal name for this class of medication) influence blood sugar regulation, digestion, appetite, and food intake. Without getting too far into the weeds, semaglutide increases insulin secretion when blood sugar is elevated, reduces glucagon, delays gastric emptying, and acts on areas of the brain involved in appetite and food reward.^[1]

This can lead to:

• Feeling satisfied with less food
• Becoming full sooner during meals
• Staying full longer afterward
• Experiencing fewer cravings or intrusive thoughts about food
• Consuming less food without needing as much deliberate restraint

One of the most influential semaglutide trials followed 1,961 adults with overweight or obesity who did not have diabetes. After 68 weeks, participants receiving 2.4 milligrams of semaglutide lost an average of 14.9% of their starting weight, compared with 2.4% in the placebo group.^[2]

More recently, a 60-week randomized trial examined what semaglutide did to appetite and eating behavior over time. At weeks 20, 40, and 60, participants receiving semaglutide ate approximately 292, 240, and 270 fewer calories, respectively, during a laboratory meal than the placebo group.^[3]

Here is where the study gets especially interesting: the participants reported noticeably less hunger early in treatment, but those subjective appetite differences were no longer statistically significant at weeks 40 and 60. But their objectively measured food intake remained lower.

Semaglutide may continue affecting how much someone eats even after the dramatic sensation of appetite suppression fades.

An Important Note on Ozempic Versus Wegovy

Ozempic and Wegovy both contain semaglutide, but they are not interchangeable labels.

Ozempic is approved to treat type 2 diabetes and reduce certain cardiovascular and kidney risks in people with diabetes. Its maximum recommended dose is 2 milligrams weekly.^[1]

Wegovy is the semaglutide product specifically approved for long-term weight management. Its adult injection doses can be higher, as demonstrated in a 2025 trial where researchers compared 7.2 milligrams weekly with 2.4 milligrams and placebo in adults with obesity.^[4]

Many of the headline-making “Ozempic weight loss studies” technically investigated Wegovy-dose semaglutide, particularly the 2.4-milligram dose.

Throughout this article, I will continue using the word Ozempic because that is how many people informally refer to semaglutide. 

First, What Does It Mean to “Not Lose Weight” on Ozempic?

Before looking for an explanation, it helps to identify which experience you are actually having.

You Have Lost Little or No Weight: This may point toward dosage, treatment duration, interruptions, a modest appetite response, another medication or health factor, or genuine biological nonresponse.

You Initially Lost Weight and Then Stopped:  That is a plateau, not necessarily nonresponse. A medication can still be exerting a meaningful effect even though your weight is no longer decreasing.

You Stopped or Interrupted Semaglutide and Began Regaining Weight: This is a withdrawal or discontinuation question. It should not be lumped together with never responding in the first place.

All three experiences can generate the same frustrated question—Why am I not losing weight on Ozempic?—but they are not the same problem.

Why Am I Not Losing Weight on Ozempic? 11 Possible Reasons

1. You Haven’t Been Taking It Long Enough

Ozempic treatment begins with a low dose so that the body can gradually adjust to the medication.

According to the current prescribing information, the starting dose is 0.25 milligrams weekly for four weeks. It is then increased to 0.5 milligrams. Further increases to 1 or 2 milligrams generally occur only after at least four weeks at the preceding dose.^[1]

The first month is therefore largely a tolerability period. Some people notice appetite or weight changes immediately, but others do not experience a substantial effect until they have spent time at a maintenance dose.

If you have only been taking Ozempic for a few weeks, your result does not tell you much about your eventual response.

2. Your Dose and Product Differ From the Ones Used in Weight Loss Trials

Someone taking 0.5 or 1 milligram of Ozempic should not automatically expect the average weight loss reported in a study of 2.4-milligram Wegovy.

This does not mean everyone needs a higher dose. Higher doses can also bring more side effects, and dosage decisions belong between you and your prescriber.

It could just mean that the evidence you are using as your benchmark may not match the treatment you are actually receiving.

Even the highly publicized 14.9% average from the 2021 trial came from 68 weeks of semaglutide at 2.4 milligrams, along with a lifestyle intervention, in people without diabetes.^[2]

That is very different from taking a lower Ozempic dose for a few months and expecting the same average outcome.

3. Your Treatment Has Been Interrupted

Medication shortages, insurance problems, cost, side effects, travel, and missed injections can all create treatment gaps.

In a real-world study of 3,389 patients, people with persistent medication coverage lost an average of 5.5% of their weight at one year. Those with fewer than 90 days of coverage lost an average of 1.8%.^[5]

Because this was an observational study, it cannot prove that medication gaps caused the entire difference. People who discontinue treatment may differ from persistent users in many ways.

4. You May Be a Genuine Low Responder

Responses to GLP-1 medications vary dramatically.

In one real-world study of 483 adults receiving semaglutide or liraglutide (another GLP-1 receptor agonist), 17.8% lost less than 5% of their starting weight and were classified as nonresponders. Approximately 48% were moderate responders, while 34% were classified as high responders.^[6]

The researchers evaluated several seemingly obvious predictors, including age, diabetes status, baseline body mass index, sedentary behavior, anxiety, and depression. Most did not independently explain who responded.

Sometimes, there is no hidden behavioral failure to uncover. Two people can take similar medications, follow similar instructions, and have very different outcomes. Average clinical-trial results cannot predict precisely what will happen to one individual.

5. You Are Taking Semaglutide for Type 2 Diabetes

People taking semaglutide for type 2 diabetes often lose weight, but average weight loss tends to be lower than it is in obesity trials that exclude diabetes.

In the study of 3,389 patients, average one-year weight loss was 3.2% when a GLP-1 medication was prescribed for type 2 diabetes versus 5.9% when it was prescribed for obesity.^[5]

Among people who persistently used semaglutide, average weight loss was approximately 5.9% in those treated for type 2 diabetes and 12.9% in those treated for obesity.

These figures are group averages, not personal predictions. Type 2 diabetes does not mean semaglutide cannot work for you. It does mean you should be cautious about comparing your results with trials composed exclusively of people without diabetes.

6. The Medication Isn’t Reducing Your Food Intake Very Much

Semaglutide produces weight loss largely by changing appetite, food reward, and energy intake.

If you have reached a maintenance dose and notice almost no change in hunger, satisfaction, cravings, food preoccupation, or portion size, the medication may simply be having a modest effect on the pathways that drive weight loss.

In the 60-week laboratory study, semaglutide reduced average food intake—but averages always contain a range of responses.^[3]

You do not necessarily need to begin rigidly counting calories to determine whether the medication is affecting you. You can instead notice whether:

• You become satisfied sooner
• Your hunger between meals has changed
• Food feels less urgent or compelling
• Your typical portions have naturally shifted
• You remain interested in food even when physically full

If very little has changed after sufficient time at an appropriate dose, that is valuable information to discuss with your prescriber.

7. Side Effects Are Interfering With Treatment

The most commonly reported Ozempic side effects include nausea, vomiting, diarrhea, abdominal pain, and constipation. The medication also delays gastric emptying.^[1]

Side effects do not always translate neatly into greater weight loss.

Persistent nausea may make eating feel chaotic rather than comfortably regulated. Someone might eat very little earlier in the day and then feel ravenous later. Fatigue or abdominal discomfort may make normal movement harder. Constipation can temporarily obscure body-weight changes on the scale. Side effects may also cause dose reductions, delayed increases, or complete discontinuation.

Severe discomfort is not evidence that the medication is “working better.”

If gastrointestinal symptoms are persistent or significantly interfering with eating, hydration, or daily life, bring the specific pattern to your prescriber rather than simply trying to tolerate more.

8. Poor Sleep Is Affecting Appetite and Eating

Sleep is not a magic weight loss intervention, nor does one bad night render Ozempic useless. But inadequate sleep can affect appetite, food motivation, energy, and eating behavior.

In a randomized trial of 80 adults with overweight who routinely slept fewer than 6.5 hours per night, a sleep-extension intervention increased sleep by approximately 1.2 hours and reduced objectively measured energy intake by an average of 270 calories per day over two weeks.^[7]

This was not an Ozempic study, and the participants were followed for only a short period. It nevertheless illustrates that sleep can meaningfully affect how much people eat without requiring a deliberate diet.

If you are chronically sleep-deprived, the most useful interpretation is not that you are sabotaging yourself. It is that your nervous system and appetite are operating under difficult conditions.

9. Stress, Emotional Eating, or Compulsion Is Still Part of the Picture

It would be inaccurate to say that Ozempic never affects the psychology of eating.

A 2025 systematic review and meta-analysis found that GLP-1 receptor agonists were associated with modest average improvements in emotional eating and restrained eating compared with placebo.^[8]

Semaglutide may reduce:

• Hunger
• Cravings
• Food reward
• Food preoccupation
• Some forms of emotional eating
• The sheer urgency that previously surrounded food

For someone who has spent years feeling tormented by food noise, that can be an enormous relief. But reducing a compulsion is not necessarily the same thing as addressing what the compulsion was doing for you.

If food has been your fastest route out of anxiety, sadness, boredom, loneliness, anger, insecurity, restlessness, or plain old emotional edginess, medication can make food less compelling without automatically teaching you how to tolerate those feelings instead.

Compulsivity is not necessarily confined to eating. Researchers increasingly describe compulsivity as a transdiagnostic tendency that can show up across many different behaviors.^[9]

So imagine that food has historically functioned as an emotional escape hatch. Before Ozempic, a difficult afternoon might lead to standing in the kitchen eating when you aren’t hungry.

Then Ozempic dramatically quiets your interest in food. Great! But what happens to the difficult afternoon?

If the underlying urge to escape discomfort is still there, you may notice yourself reaching for something else instead:

• Shopping or spending
• Working excessively
• Obsessing over productivity
• Scrolling for hours
• Overexercising
• Checking your phone constantly
• Drinking or using another rewarding behavior to take the edge off

Removing one coping mechanism does not automatically build emotional regulation. If you previously needed food to buffer yourself from discomfort, and medication dramatically weakens that outlet, it provides an opportunity to ask:

What was I using the food to get away from in the first place?

That question gets much closer to the root.

If overeating is still part of the picture for you—such as regularly eating when you aren’t hungry or continuing past comfortable fullness—see my guide on how to stop overeating, where I go much deeper into the psychology behind it.

10. Other Medications, Health Factors, or Body Changes Are Involved

Body weight is affected by more than appetite alone.

Other medications may promote weight gain or alter blood sugar, appetite, energy, or fluid balance. Endocrine conditions, constipation, hormonal transitions, menstrual-cycle changes, edema, and changes in activity can all influence the number on the scale.

That does not mean every person who plateaus needs an exhaustive medical investigation. It means that a medication review and basic clinical assessment can be worthwhile, especially if:

• Your weight changed abruptly
• You have new fatigue, cold intolerance, weakness, or swelling
• Another medication was recently started or increased
• Your appetite has decreased substantially but your weight has not changed
• Your symptoms suggest that something other than body fat is influencing the scale

Conditions such as insulin resistance or polycystic ovary syndrome should not automatically be treated as explanations for why semaglutide isn’t producing results. GLP-1 medications may still produce weight loss in people with these conditions. The goal is to look at the whole clinical picture.

11. You Have Reached a Normal Weight Loss Plateau

If you initially lost a meaningful amount of weight and then stabilized, Ozempic may not have stopped working.

In a four-year study of semaglutide, average weight loss with 2.4-milligram semaglutide continued until approximately week 65 and then plateaued. That lower average weight was substantially maintained through week 208, when the semaglutide group remained 10.2% below its starting weight compared with 1.5% in the placebo group.^[10]

A plateau does not necessarily mean the treatment effect has disappeared. Weight loss curves in long-term trials do not continue downward forever. At some point, average weight stabilizes.

If the number on the scale has stopped changing after meaningful weight loss, the medication may still be influencing appetite and helping maintain that change even though it is no longer producing additional loss.

What Happens If You Stop Ozempic or Semaglutide?

Stopping semaglutide is different from never responding to it.

Researchers also followed 327 participants for one year after treatment ended. During the original 68-week treatment period, participants receiving semaglutide had lost an average of 17.3% of their starting weight. One year after withdrawal, they had regained 11.6 percentage points—approximately two-thirds of the weight they had lost.^[11]

It’s absolutely worth pointing out that both semaglutide and the structured lifestyle intervention were discontinued at the end of the treatment phase. The results therefore do not isolate medication withdrawal from every other change.

But the direction of the evidence is clear: substantial regain after semaglutide discontinuation is common.

A 2026 systematic review examined 37 studies involving 9,341 participants who stopped weight-management medications. Across the medications studied, average regain occurred at approximately 0.4 kilograms per month after treatment ended.^[12]

The average follow-up was relatively short, so longer-term projections carry uncertainty. The findings also represent averages across different medications, treatment lengths, and populations.

They do not mean that everyone regains all of the weight. They do mean that semaglutide is often better understood as an ongoing treatment than as a temporary intervention.

Regain Is Not Proof of Personal Failure

When a medication changes appetite, food reward, and energy intake, removing that medication can change those processes again.

That does not prove that someone lacked discipline, failed to learn the right habits, or should have restricted food more aggressively after stopping.

The possibility of regain also does not tell you whether you personally should continue or discontinue Ozempic. That decision depends on treatment benefits, side effects, health risks, access, preferences, and your prescriber’s guidance.

It simply means the decision should be made with realistic expectations rather than the assumption that a temporary injection will permanently change the body after treatment ends.

Ozempic or Not? How to Move Forward Without Intensifying Food Fear

Someone who is terrified of weight gain usually does not need to be told immediately to throw away every food rule and begin intuitive eating tomorrow.

The emotional work can come first.

You can begin exploring your relationship with food while taking Ozempic, while considering a medication change, or while planning to continue indefinitely. Psychological healing and medical treatment are not mutually exclusive.

1. Clarify What Has Actually Happened Medically

Before interpreting your result as failure, review the practical facts:

• How long have you been taking semaglutide?
• How long have you been at your current dose?
• Are you taking Ozempic or Wegovy?
• Has treatment been interrupted?
• Did your appetite or food preoccupation change?
• Did you initially lose weight and then stabilize?
• Are side effects interfering with consistent treatment?
• Are other medications or health changes relevant?

Bring this timeline to your prescriber.

The goal is not automatically to stop Ozempic. It is to discuss whether continuing, changing the dose, changing medications, addressing side effects, or discontinuing makes sense for your specific situation.

2. Start Looking for the Compulsion Beneath the Food

When food has been your primary way of escaping discomfort, it can be difficult to recognize what the food was helping you avoid. The urge may have felt like hunger, but it may also have been a response to stress, loneliness, boredom, anger, insecurity, restlessness, or emotional discomfort.

Ozempic may quiet food noise enough for you to notice those moments more clearly. This can provide a beautiful opportunity to notice where else that underlying discomfort may pop up.

For example, you might notice that you reach for your phone after a difficult conversation, shop online when you feel inadequate, or work late to avoid feeling lonely.

These behaviors are not automatically unhealthy. Shopping, working, scrolling, researching, exercising, watching television, and eating for pleasure can all be ordinary parts of life. The more useful question is whether you feel free to choose the behavior—or whether you feel driven to use it to get away from yourself.

If a behavior feels increasingly urgent, repetitive, or difficult to stop, pause before labeling it as a new addiction or assuming that Ozempic caused it. Instead, ask what emotional experience you may be trying not to feel.

The goal is not to replace emotional eating with a “healthier” distraction. It is to develop the capacity to remain present with discomfort so that you have more choice in how you respond.

3. Don’t Force Yourself Into Intuitive Eating Before You’re Ready

Intuitive eating can sound terrifying to someone who relies on food rules for a sense of safety.

If you are intensely afraid of weight gain, suddenly eliminating every rule may cause so much anxiety that you rebound into stricter dieting—or interpret any uncomfortable eating experience as proof that intuitive eating is dangerous.

You do not have to rip away your coping mechanisms before you have developed new ones.

You can begin with emotional awareness and emotional tolerance while observing your food rules with curiosity:

• Which rules actually help me feel physically good?
• Which rules are driven primarily by fear?
• Which rules trigger deprivation or binge eating?
• Which rules feel impossible to break without panic?
• What do I believe would happen if I stopped following this rule?
• What emotional function does this rule serve?

Readiness matters.

Building emotional skills first does not mean you are failing at intuitive eating. It means you are creating enough internal safety to approach it more sustainably.

If fear of weight gain is the biggest thing holding you back from intuitive eating, read my article on intuitive eating and the fear of weight gain. You can also watch my video on the topic below, which I created because of how normal and common this fear is.